US4479795A
(en)
*
|
1979-06-29 |
1984-10-30 |
The Procter & Gamble Company |
Antimicrobial polymer compositions
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US5366738A
(en)
*
|
1982-07-29 |
1994-11-22 |
Merck & Co., Inc. |
Controlled release drug dispersion delivery device
|
US4709996A
(en)
*
|
1982-09-30 |
1987-12-01 |
Michelson Paul E |
Fluid lens
|
US4466705A
(en)
*
|
1982-09-30 |
1984-08-21 |
Michelson Paul E |
Fluid lens
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
GB8305797D0
(en)
*
|
1983-03-02 |
1983-04-07 |
Graham N B |
Hydrogel-containing envelopes
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
AT394944B
(de)
*
|
1983-05-11 |
1992-07-27 |
Alza Corp |
Verfahren zur herstellung einer vorrichtung zur abgabe eines wirkstoffes, insbesondere eines heilmittels, an eine waesserige verwendungsumgebung
|
NZ206600A
(en)
*
|
1983-05-11 |
1987-01-23 |
Alza Corp |
Osmotic drug delivery device
|
USRE33994E
(en)
*
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
AU591171B2
(en)
*
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4781714A
(en)
*
|
1983-11-02 |
1988-11-01 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US4717566A
(en)
*
|
1984-03-19 |
1988-01-05 |
Alza Corporation |
Dosage system and method of using same
|
US4772474A
(en)
*
|
1985-08-09 |
1988-09-20 |
Alza Corporation |
Dispenser with internal arrangement of lamina means for dispensing beneficial agent
|
US4595583A
(en)
*
|
1984-03-19 |
1986-06-17 |
Alza Corporation |
Delivery system controlled administration of beneficial agent to ruminants
|
US4624945A
(en)
*
|
1984-03-19 |
1986-11-25 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4927633A
(en)
*
|
1984-03-19 |
1990-05-22 |
Alza Corporation |
Dispenser for delivering drug to livestock
|
US4678467A
(en)
*
|
1984-03-21 |
1987-07-07 |
Alza Corporation |
Dispenser comprising capsule with volume displacing member
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
GB2155889B
(en)
*
|
1984-03-21 |
1988-03-02 |
Alza Corp |
Dispenser-capsule
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4627971A
(en)
*
|
1985-04-22 |
1986-12-09 |
Alza Corporation |
Osmotic device with self-sealing passageway
|
US4624847A
(en)
*
|
1985-04-22 |
1986-11-25 |
Alza Corporation |
Drug delivery device for programmed delivery of beneficial drug
|
US4717718A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Device for the controlled delivery of a beneficial agent
|
US4717568A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Laminar arrangement for increasing delivery of beneficial agent from dispenser
|
US4966767A
(en)
*
|
1985-08-16 |
1990-10-30 |
Alza Corporation |
Ruminant dispensing device comprising agent displacement member
|
US4963141A
(en)
*
|
1985-08-16 |
1990-10-16 |
Alza Corporation |
Dispensing system for administering beneficial agent formulation to ruminants
|
US4704118A
(en)
*
|
1985-08-16 |
1987-11-03 |
Alza Corporation |
Ruminant dispensing device with thermo-activated memory
|
US5098425A
(en)
*
|
1985-08-16 |
1992-03-24 |
Alza Corporation |
Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
|
US4865598A
(en)
*
|
1985-08-16 |
1989-09-12 |
Alza Corporation |
Dispensing system for administering beneficial agent
|
US4955881A
(en)
*
|
1985-08-16 |
1990-09-11 |
Alza Corporation |
Ruminant dispensing device
|
US4883667A
(en)
*
|
1985-08-16 |
1989-11-28 |
Alza Corporation |
Process for forming dispensing device
|
US4871544A
(en)
*
|
1985-08-16 |
1989-10-03 |
Alza Corporation |
Ruminant dispensing device
|
US4643731A
(en)
*
|
1985-08-16 |
1987-02-17 |
Alza Corporation |
Means for providing instant agent from agent dispensing system
|
US5008288A
(en)
*
|
1986-01-06 |
1991-04-16 |
Alfred Stracher |
Carnitine directed pharmaceutical agents
|
US4866040A
(en)
*
|
1986-01-06 |
1989-09-12 |
Alfred Stracher |
Aminocarnitine directed pharmaceutical agents
|
US4723957A
(en)
*
|
1986-02-07 |
1988-02-09 |
Alza Corp. |
System for delivering drug with enhanced bioacceptability
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
US4865845A
(en)
*
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
GB2189702B
(en)
*
|
1986-04-30 |
1989-10-18 |
Alza Corp |
Dosage form with improved delivery capability
|
US4960416A
(en)
*
|
1986-04-30 |
1990-10-02 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4863456A
(en)
*
|
1986-04-30 |
1989-09-05 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4723958A
(en)
*
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
US4983400A
(en)
*
|
1986-06-16 |
1991-01-08 |
Merck & Co., Inc. |
Controlled release combination of carbidopa/levodopa
|
US4755180A
(en)
*
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
CH668187A5
(de)
*
|
1986-08-07 |
1988-12-15 |
Ciba Geigy Ag |
Therapeutisches system mit systemischer wirkung.
|
USRE34990E
(en)
*
|
1986-08-07 |
1995-07-04 |
Ciba-Geigy Corporation |
Oral therapeutic system having systemic action
|
EP0277092B1
(de)
*
|
1987-01-14 |
1992-01-29 |
Ciba-Geigy Ag |
Therapeutisches System für schwerlösliche Wirkstoffe
|
JPS63180224A
(ja)
*
|
1987-01-21 |
1988-07-25 |
Matsushita Electric Ind Co Ltd |
無線機のアンテナ回路
|
US4892778A
(en)
*
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US4940465A
(en)
*
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US4876093A
(en)
*
|
1987-07-02 |
1989-10-24 |
Alza Corporation |
Dispenser with dispersing member for delivering beneficial agent
|
US4824675A
(en)
*
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4915949A
(en)
*
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4891223A
(en)
*
|
1987-09-03 |
1990-01-02 |
Air Products And Chemicals, Inc. |
Controlled release delivery coating formulation for bioactive substances
|
US4950486A
(en)
*
|
1987-10-02 |
1990-08-21 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4946687A
(en)
*
|
1987-10-02 |
1990-08-07 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4816263A
(en)
*
|
1987-10-02 |
1989-03-28 |
Alza Corporation |
Dosage form for treating cardiovascular diseases comprising isradipine
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5030456A
(en)
*
|
1988-11-07 |
1991-07-09 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US5376383A
(en)
*
|
1988-11-21 |
1994-12-27 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma-cholesterol levels
|
US4997658A
(en)
*
|
1988-11-21 |
1991-03-05 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma cholesterol levels
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
IE69174B1
(en)
*
|
1989-01-31 |
1996-08-07 |
Int Pharma Agentur |
A system for the controlled release of active agents and a process for its preparation
|
DD295760A5
(de)
*
|
1989-01-31 |
1991-11-14 |
Martin-Luther-Universitaet Halle Wittenberg,De |
Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
|
US6200600B1
(en)
*
|
1989-02-16 |
2001-03-13 |
Btg International Limited |
Controlled delay release device
|
US5181505A
(en)
*
|
1989-03-08 |
1993-01-26 |
Lew Chel W |
Method and apparatus for delivery of a medicament in the oral cavity
|
US5002540A
(en)
*
|
1989-05-22 |
1991-03-26 |
Warren Kirschbaum |
Intravaginal device and method for delivering a medicament
|
US5776493A
(en)
*
|
1989-07-14 |
1998-07-07 |
Alza Corporation |
Oral osmotic device for delivery of nystatin with hydrogel driving member
|
US5021053A
(en)
*
|
1989-07-14 |
1991-06-04 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5030216A
(en)
*
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5660851A
(en)
*
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5128145A
(en)
*
|
1990-06-13 |
1992-07-07 |
Alza Corporation |
Dosage form for Parkinson's disease, spasticity and muscle spasms
|
US5057321A
(en)
*
|
1990-06-13 |
1991-10-15 |
Alza Corporation |
Dosage form comprising drug and maltodextrin
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
NZ238867A
(en)
*
|
1990-07-12 |
1993-08-26 |
Alza Corp |
Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
|
US5147654A
(en)
*
|
1990-07-23 |
1992-09-15 |
Alza Corporation |
Oral osmotic device for delivering nicotine
|
ATE106015T1
(de)
*
|
1990-09-28 |
1994-06-15 |
Pfizer |
Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5593852A
(en)
|
1993-12-02 |
1997-01-14 |
Heller; Adam |
Subcutaneous glucose electrode
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5208037A
(en)
*
|
1991-04-22 |
1993-05-04 |
Alza Corporation |
Dosage forms comprising polymers comprising different molecular weights
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5252338A
(en)
*
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
US5190765A
(en)
*
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
AU2867492A
(en)
*
|
1991-10-10 |
1993-05-03 |
Alza Corporation |
Osmotic drug delivery devices with hydrophobic wall materials
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
US5543154A
(en)
*
|
1991-12-27 |
1996-08-06 |
Merck & Co., Inc. |
Controlled release nifedipine delivery device
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
US5248310A
(en)
*
|
1992-03-27 |
1993-09-28 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5512299A
(en)
*
|
1992-03-30 |
1996-04-30 |
Alza Corporation |
Method of treating oral inflammatory disease
|
US5869097A
(en)
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
US5573776A
(en)
*
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
HU213407B
(en)
*
|
1993-12-09 |
1997-06-30 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing tablet with diffusive-osmotic release
|
US5474985A
(en)
*
|
1993-12-22 |
1995-12-12 |
The Regents Of The University Of California |
Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
|
GB9326267D0
(en)
*
|
1993-12-23 |
1994-02-23 |
Scherer Corp R P |
Expulsion of material
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US5540665A
(en)
*
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5460826A
(en)
*
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5529787A
(en)
*
|
1994-07-07 |
1996-06-25 |
Alza Corporation |
Hydromorphone therapy
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
IE70735B1
(en)
*
|
1994-08-15 |
1996-12-11 |
Elan Med Tech |
Orally administrable delivery device
|
US5837276A
(en)
*
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
US5582591A
(en)
*
|
1994-09-02 |
1996-12-10 |
Delab |
Delivery of solid drug compositions
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5614578A
(en)
*
|
1994-10-28 |
1997-03-25 |
Alza Corporation |
Injection-molded dosage form
|
US5582838A
(en)
*
|
1994-12-22 |
1996-12-10 |
Merck & Co., Inc. |
Controlled release drug suspension delivery device
|
US5534263A
(en)
*
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5651979A
(en)
*
|
1995-03-30 |
1997-07-29 |
Gel Sciences, Inc. |
Apparatus and method for delivering a biologically active compound into a biological environment
|
US5876741A
(en)
*
|
1995-03-30 |
1999-03-02 |
Medlogic Global Corporation |
Chemo-mechanical expansion delivery system
|
SI9500173B
(sl)
*
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
US6262115B1
(en)
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
US6124355A
(en)
*
|
1995-05-22 |
2000-09-26 |
Guittard; George V. |
Oxybutynin therapy
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5780058A
(en)
*
|
1995-07-21 |
1998-07-14 |
Alza Corporation |
Oral delivery of discrete units
|
US5840332A
(en)
*
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
AU2059297A
(en)
*
|
1996-03-12 |
1997-10-01 |
Alza Corporation |
Composition and dosage form comprising opioid antagonist
|
ZA97976B
(en)
*
|
1996-04-05 |
1997-08-18 |
Alza Corp |
Uniform drug delivery theraphy.
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
DK0957899T3
(da)
*
|
1996-08-16 |
2003-04-22 |
Alza Corp |
Doseringsform til tilvejebringelse af stigende dosis lægemiddel
|
CA2268887C
(en)
*
|
1996-10-18 |
2003-11-25 |
Alza Corporation |
Closure system for an active agent delivery device
|
US6024721A
(en)
*
|
1996-10-18 |
2000-02-15 |
Alza Corporation |
Mixing system for an active agent delivery device
|
AU729905B2
(en)
*
|
1996-10-18 |
2001-02-15 |
Alza Corporation |
Multiple flow path device for oral delivery of discrete units
|
JP4863534B2
(ja)
*
|
1996-10-25 |
2012-01-25 |
スパーナス ファーマシューティカルズ インコーポレイテッド |
可溶形態浸透用量送達システム
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
EP1782798A3
(en)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Ascending-dose dosage form
|
AU5267698A
(en)
*
|
1996-11-25 |
1998-06-22 |
Alza Corporation |
Ascending-dose dosage form
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US5922352A
(en)
*
|
1997-01-31 |
1999-07-13 |
Andrx Pharmaceuticals, Inc. |
Once daily calcium channel blocker tablet having a delayed release core
|
US5837379A
(en)
*
|
1997-01-31 |
1998-11-17 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US20030100532A1
(en)
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
US5948787A
(en)
*
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
US5985324A
(en)
|
1997-05-16 |
1999-11-16 |
Alza Corporation |
Flow controller configurations for an active agent delivery device
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
US7060734B1
(en)
|
1997-09-09 |
2006-06-13 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
DE69827650T2
(de)
|
1997-09-09 |
2005-11-03 |
Alza Corp., Mountain View |
Pharmazeutische Überzugszusammensetzung und Verfahren zum Beschichten einer Dosierungsform hiermit
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
MY122499A
(en)
|
1997-11-10 |
2006-04-29 |
Searle & Co |
Use of alkylated iminosugars to treat multidrug resistance
|
AU1534699A
(en)
|
1997-12-05 |
1999-06-28 |
Alza Corporation |
Osmotic dosage form comprising first and second coats
|
US6485748B1
(en)
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
KR100576583B1
(ko)
|
1997-12-22 |
2006-05-04 |
알자 코포레이션 |
서방성 약물 송달 장치용 속도 조절막
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
BR9907882A
(pt)
|
1998-02-12 |
2000-10-17 |
Searle & Co |
Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite
|
US6134461A
(en)
|
1998-03-04 |
2000-10-17 |
E. Heller & Company |
Electrochemical analyte
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6949816B2
(en)
|
2003-04-21 |
2005-09-27 |
Motorola, Inc. |
Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6365183B1
(en)
*
|
1998-05-07 |
2002-04-02 |
Alza Corporation |
Method of fabricating a banded prolonged release active agent dosage form
|
KR100827254B1
(ko)
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
US7890176B2
(en)
*
|
1998-07-06 |
2011-02-15 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating chronic pelvic pain
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
US7303768B2
(en)
*
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
RU2224523C2
(ru)
|
1998-07-24 |
2004-02-27 |
Сео Хонг Ю |
Водный раствор, содержащий желчную кислоту, и способ его получения
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
CN1227003C
(zh)
*
|
1998-09-09 |
2005-11-16 |
阿尔萨公司 |
包括液体制剂的剂型
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6087396A
(en)
*
|
1998-10-05 |
2000-07-11 |
Situs Corporation |
Oxybutynin formulations and method of use
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
IL143691A0
(en)
|
1998-12-17 |
2002-04-21 |
Alza Corp |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
EP1140039B1
(en)
|
1998-12-18 |
2009-11-04 |
Alza Corporation |
Transparent transdermal nicotine delivery devices
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
WO2000040089A1
(en)
*
|
1999-01-05 |
2000-07-13 |
Massachusetts Eye And Ear Infirmary |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
ATE433318T1
(de)
|
1999-02-10 |
2009-06-15 |
Pfizer Prod Inc |
Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
|
US6545021B1
(en)
|
1999-02-12 |
2003-04-08 |
G.D. Searle & Co. |
Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
|
WO2001008672A2
(en)
|
1999-02-12 |
2001-02-08 |
G.D. Searle & Co. |
Glucamine compounds for treating hepatitis virus infections
|
US6210716B1
(en)
|
1999-02-26 |
2001-04-03 |
Andrx Pharmaceuticals, Inc. |
Controlled release bupropion formulation
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
US8545880B2
(en)
*
|
1999-02-26 |
2013-10-01 |
Andrx Pharmaceuticals, Llc |
Controlled release oral dosage form
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
US6541021B1
(en)
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217896B1
(en)
*
|
1999-04-01 |
2001-04-17 |
Uab Research Foundation |
Conjunctival inserts for topical delivery of medication or lubrication
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US6287870B1
(en)
*
|
1999-08-20 |
2001-09-11 |
Robert A. Levine |
Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
CO5210862A1
(es)
|
1999-09-15 |
2002-10-30 |
Alza Corp |
Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
|
US6387325B1
(en)
*
|
1999-10-08 |
2002-05-14 |
Becton Dickinson & Company |
Assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
KR100732262B1
(ko)
|
1999-10-21 |
2007-06-25 |
알콘, 인코퍼레이티드 |
약물 전달 장치
|
AU775149B2
(en)
|
1999-10-21 |
2004-07-22 |
Alcon Inc. |
Sub-tenon drug delivery
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
MXPA02006335A
(es)
|
1999-12-23 |
2002-12-13 |
Pfizer Prod Inc |
Forma de dosificacion de farmaco en capas impulsada por hidrogel.
|
DE60038698T2
(de)
*
|
1999-12-23 |
2009-05-07 |
Pfizer Products Inc., Groton |
Hydrogel-gesteuerte dosierungsform
|
DE19962924A1
(de)
*
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
WO2001056547A2
(en)
*
|
2000-02-04 |
2001-08-09 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
CN1422156A
(zh)
*
|
2000-02-14 |
2003-06-04 |
法马西亚公司 |
N-取代的-1,5-二脱氧-1,5-亚氨基-d-葡萄糖醇化合物在治疗肝炎病毒感染中的用途
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
US6582441B1
(en)
|
2000-02-24 |
2003-06-24 |
Advanced Bionics Corporation |
Surgical insertion tool
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US7989436B2
(en)
*
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
AU2001257359A1
(en)
|
2000-04-27 |
2001-11-07 |
Verion Inc. |
Zero order release and temperature-controlled microcapsules and process for the preparation thereof
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US20030086972A1
(en)
*
|
2000-08-09 |
2003-05-08 |
Appel Leah E. |
Hydrogel-driven drug dosage form
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
AU2002236495B2
(en)
|
2000-11-29 |
2006-05-11 |
Allergan, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
US20050070883A1
(en)
*
|
2000-11-29 |
2005-03-31 |
Brown James E |
Devices and methods for controlled delivery from a drug delivery device
|
US6560471B1
(en)
|
2001-01-02 |
2003-05-06 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US20060064140A1
(en)
*
|
2001-01-30 |
2006-03-23 |
Whitehurst Todd K |
Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
|
US7493172B2
(en)
*
|
2001-01-30 |
2009-02-17 |
Boston Scientific Neuromodulation Corp. |
Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
|
US20050143789A1
(en)
*
|
2001-01-30 |
2005-06-30 |
Whitehurst Todd K. |
Methods and systems for stimulating a peripheral nerve to treat chronic pain
|
IN190699B
(es)
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
WO2002074285A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Andrx Corporation |
Controlled release sulfonylurea formulation
|
US7041468B2
(en)
|
2001-04-02 |
2006-05-09 |
Therasense, Inc. |
Blood glucose tracking apparatus and methods
|
US6632217B2
(en)
*
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
JP2004536631A
(ja)
|
2001-05-03 |
2004-12-09 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
移植可能な薬物送達デバイスおよびその使用
|
WO2002100318A2
(en)
|
2001-06-12 |
2002-12-19 |
Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
DE10129725A1
(de)
*
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US20040180087A1
(en)
*
|
2001-06-21 |
2004-09-16 |
Boyong Li |
Stable controlled release pharmaceutical compositions containing pravastatin
|
MXPA03011609A
(es)
|
2001-07-23 |
2004-07-01 |
Alcon Inc |
Dispositivo de entrega de droga oftalmica.
|
CN100349562C
(zh)
*
|
2001-07-23 |
2007-11-21 |
爱尔康公司 |
眼部药物输送装置
|
US20030091634A1
(en)
*
|
2001-09-14 |
2003-05-15 |
Pawan Seth |
Delayed release tablet of venlafaxin
|
BR0212950A
(pt)
*
|
2001-09-28 |
2004-10-26 |
Mcneil Ppc Inc |
Formas de dosagens compósitas tendo uma porção inserida
|
US20030153864A1
(en)
*
|
2001-10-16 |
2003-08-14 |
Bernard Chaffringeon |
Disposable device and method for transferring an active liquid into a body cavity
|
US8329217B2
(en)
*
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
US20030185882A1
(en)
*
|
2001-11-06 |
2003-10-02 |
Vergez Juan A. |
Pharmaceutical compositions containing oxybutynin
|
US7183321B2
(en)
*
|
2001-12-17 |
2007-02-27 |
Bristol-Myers Squibb Company |
Antidiabetic formulation and method
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
US8364229B2
(en)
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US9247901B2
(en)
|
2003-08-22 |
2016-02-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8010174B2
(en)
|
2003-08-22 |
2011-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US7613491B2
(en)
|
2002-05-22 |
2009-11-03 |
Dexcom, Inc. |
Silicone based membranes for use in implantable glucose sensors
|
US8260393B2
(en)
|
2003-07-25 |
2012-09-04 |
Dexcom, Inc. |
Systems and methods for replacing signal data artifacts in a glucose sensor data stream
|
EP2266590A3
(en)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Active agent delivery sytems and methods for protecting and administering active agents
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
MXPA04009701A
(es)
*
|
2002-04-05 |
2005-05-27 |
Penwest Pharmaceuticals Co |
Formulaciones de metoprolol de liberacion sostenida.
|
US7125563B2
(en)
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US6733526B2
(en)
|
2002-04-25 |
2004-05-11 |
Advanced Medical Optics, Inc. |
Method of improving adherence and centering of intra-corneal implants on corneal bed
|
US20040010000A1
(en)
*
|
2002-04-29 |
2004-01-15 |
Ayer Atul D. |
Methods and dosage forms for controlled delivery of oxycodone
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US7328706B2
(en)
|
2002-05-06 |
2008-02-12 |
Dynamic Mouth Devices Llc |
Therapeutic and protective dental device useful as an intra-oral delivery system
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7151961B1
(en)
*
|
2002-05-24 |
2006-12-19 |
Advanced Bionics Corporation |
Treatment of movement disorders by brain stimulation
|
JP2005528423A
(ja)
*
|
2002-05-31 |
2005-09-22 |
アルザ・コーポレーシヨン |
オキシコドンの変動性投薬用量の浸透圧的送達のための剤形および組成物
|
US20040043067A1
(en)
*
|
2002-06-19 |
2004-03-04 |
Salamone Joseph C. |
Fluorosiloxane matrix controlled diffusion drug delivery systems
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
CA2494233A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US7254449B2
(en)
*
|
2002-07-31 |
2007-08-07 |
Advanced Bionics Corp |
Systems and methods for providing power to one or more implantable devices
|
AU2002331830A1
(en)
|
2002-09-06 |
2004-03-29 |
Durect Corporation |
Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
|
US20060009739A1
(en)
*
|
2002-09-06 |
2006-01-12 |
Durect Corporation |
Implantable flow regulator with failsafe mode and reserve drug supply
|
EP1551372B8
(en)
*
|
2002-09-20 |
2018-08-01 |
Alpharma Pharmaceuticals LLC |
Sequestering subunit and related compositions and methods
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
US20040091538A1
(en)
*
|
2002-10-31 |
2004-05-13 |
Crystal Pollock-Dove |
Dosage form providing ascending release of liquid formulation
|
US7381184B2
(en)
|
2002-11-05 |
2008-06-03 |
Abbott Diabetes Care Inc. |
Sensor inserter assembly
|
GB2395126A
(en)
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
EP2959893A1
(en)
|
2002-12-13 |
2015-12-30 |
DURECT Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
EP1578262A4
(en)
|
2002-12-31 |
2007-12-05 |
Therasense Inc |
CONTINUOUS BLOOD SUGAR MONITORING SYSTEM AND USE METHOD
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
CA2512786A1
(en)
*
|
2003-01-14 |
2004-08-05 |
Alza Corporation |
Methods and dosage forms with modified viscosity layers
|
JP3811127B2
(ja)
*
|
2003-01-30 |
2006-08-16 |
株式会社東芝 |
情報記録装置及び情報記録方法
|
DE602004015246D1
(de)
*
|
2003-02-11 |
2008-09-04 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
CA2521471A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Barr Laboratories, Inc. |
Methods of administering estrogens and progestins
|
US20040213850A1
(en)
*
|
2003-04-25 |
2004-10-28 |
Eleni Dokou |
Sustained release delivery of a thrombin inhibitor
|
US20070083240A1
(en)
*
|
2003-05-08 |
2007-04-12 |
Peterson David K L |
Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
|
JP2007525188A
(ja)
|
2003-05-16 |
2007-09-06 |
インターミューン インコーポレイテッド |
合成ケモカイン受容体リガンドおよびその使用方法
|
US8066639B2
(en)
|
2003-06-10 |
2011-11-29 |
Abbott Diabetes Care Inc. |
Glucose measuring device for use in personal area network
|
US20040253293A1
(en)
*
|
2003-06-16 |
2004-12-16 |
Afshin Shafiee |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
US8802139B2
(en)
*
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
US9763609B2
(en)
|
2003-07-25 |
2017-09-19 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
WO2007120442A2
(en)
|
2003-07-25 |
2007-10-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US7774145B2
(en)
|
2003-08-01 |
2010-08-10 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US20190357827A1
(en)
|
2003-08-01 |
2019-11-28 |
Dexcom, Inc. |
Analyte sensor
|
US8275437B2
(en)
|
2003-08-01 |
2012-09-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
EP1653922A2
(en)
*
|
2003-08-06 |
2006-05-10 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US20140121989A1
(en)
|
2003-08-22 |
2014-05-01 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US8233959B2
(en)
|
2003-08-22 |
2012-07-31 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
CA2564227A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
MXPA06003450A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
|
ATE504288T1
(de)
*
|
2003-09-26 |
2011-04-15 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
NZ546183A
(en)
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
KR20060095765A
(ko)
*
|
2003-09-26 |
2006-09-01 |
알자 코포레이션 |
알프라졸람의 제어 송달용 삼투성 제형
|
WO2005040758A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US7299082B2
(en)
|
2003-10-31 |
2007-11-20 |
Abbott Diabetes Care, Inc. |
Method of calibrating an analyte-measurement device, and associated methods, devices and systems
|
EP1677757A2
(en)
*
|
2003-10-31 |
2006-07-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption
|
US20050118246A1
(en)
*
|
2003-10-31 |
2005-06-02 |
Wong Patrick S. |
Dosage forms and layered deposition processes for fabricating dosage forms
|
USD914881S1
(en)
|
2003-11-05 |
2021-03-30 |
Abbott Diabetes Care Inc. |
Analyte sensor electronic mount
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
BRPI0415764A
(pt)
|
2003-11-28 |
2006-12-26 |
Eastman Chem Co |
interpolìmero, produto de reação, métodos para converter uma hidroxila, para preparar uma forma estável de um interpolìmero, para converter um álcool primário, e para tratar um mamìfero necessitado do mesmo, composições para revestimento e farmacêutica oral, dispersão de pigmento, e, artigo
|
US8423114B2
(en)
|
2006-10-04 |
2013-04-16 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
EP2256493B1
(en)
|
2003-12-05 |
2014-02-26 |
DexCom, Inc. |
Calibration techniques for a continuous analyte sensor
|
US11633133B2
(en)
|
2003-12-05 |
2023-04-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
WO2005062829A2
(en)
*
|
2003-12-19 |
2005-07-14 |
Advanced Bionics Corporation |
Skull-mounted electrical stimulation system and method for treating patients
|
AU2004308973A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
MXPA06007509A
(es)
*
|
2003-12-29 |
2007-10-18 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas.
|
AU2004312084A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc. |
Novel drug compositions and dosage forms of topiramate
|
AU2005209201B2
(en)
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
EP1718198A4
(en)
|
2004-02-17 |
2008-06-04 |
Therasense Inc |
METHOD AND SYSTEM FOR PROVIDING DATA COMMUNICATION IN A CONTINUOUS BLOOD SUGAR MONITORING AND MANAGEMENT SYSTEM
|
US8808228B2
(en)
|
2004-02-26 |
2014-08-19 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050226929A1
(en)
*
|
2004-04-12 |
2005-10-13 |
Jianbo Xie |
Controlled release opioid analgesic formulation
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8512738B2
(en)
*
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20050267555A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Marnfeldt Goran N |
Engagement tool for implantable medical devices
|
US20060010098A1
(en)
|
2004-06-04 |
2006-01-12 |
Goodnow Timothy T |
Diabetes care host-client architecture and data management system
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
WO2006010013A1
(en)
*
|
2004-07-09 |
2006-01-26 |
Advanced Bionics Corporation |
Systems and methods for using a butterfly coil to communicate with or transfer power to an implantable medical device
|
EP1773350B1
(en)
*
|
2004-07-12 |
2013-05-29 |
Allergan, Inc. |
Opthalmic compositions for treating ophthalmic conditions
|
US7783333B2
(en)
|
2004-07-13 |
2010-08-24 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
US7905833B2
(en)
|
2004-07-13 |
2011-03-15 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8565848B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8170803B2
(en)
|
2004-07-13 |
2012-05-01 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8452368B2
(en)
|
2004-07-13 |
2013-05-28 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20070045902A1
(en)
|
2004-07-13 |
2007-03-01 |
Brauker James H |
Analyte sensor
|
US7640048B2
(en)
|
2004-07-13 |
2009-12-29 |
Dexcom, Inc. |
Analyte sensor
|
US8452407B2
(en)
*
|
2004-08-16 |
2013-05-28 |
Boston Scientific Neuromodulation Corporation |
Methods for treating gastrointestinal disorders
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
JP2008511651A
(ja)
*
|
2004-08-30 |
2008-04-17 |
セオ ホン ユー |
局所虚血モデルでの可溶化udcaの神経保護効果
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
US7780981B2
(en)
|
2004-09-13 |
2010-08-24 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
BRPI0518191A
(pt)
*
|
2004-10-15 |
2008-11-04 |
Seo Hong Yoo |
métodos e composições para reduzir a toxicidade de um composto farmacêutico
|
CA2585471A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
US9358393B1
(en)
|
2004-11-09 |
2016-06-07 |
Andres M. Lozano |
Stimulation methods and systems for treating an auditory dysfunction
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US7483746B2
(en)
*
|
2004-12-06 |
2009-01-27 |
Boston Scientific Neuromodulation Corp. |
Stimulation of the stomach in response to sensed parameters to treat obesity
|
US9095713B2
(en)
*
|
2004-12-21 |
2015-08-04 |
Allison M. Foster |
Methods and systems for treating autism by decreasing neural activity within the brain
|
US20060161217A1
(en)
*
|
2004-12-21 |
2006-07-20 |
Jaax Kristen N |
Methods and systems for treating obesity
|
US20070038264A1
(en)
*
|
2004-12-21 |
2007-02-15 |
Jaax Kristen N |
Methods and systems for treating autism
|
US9327069B2
(en)
|
2004-12-21 |
2016-05-03 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a medical condition by promoting neural remodeling within the brain
|
CA2588692A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Alcon, Inc. |
Device for ophthalmic drug delivery
|
US8515541B1
(en)
|
2004-12-22 |
2013-08-20 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating post-stroke disorders
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US9352145B2
(en)
*
|
2004-12-22 |
2016-05-31 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a psychotic disorder
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US7731657B2
(en)
*
|
2005-08-30 |
2010-06-08 |
Abbott Diabetes Care Inc. |
Analyte sensor introducer and methods of use
|
US8613703B2
(en)
|
2007-05-31 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Insertion devices and methods
|
US9743862B2
(en)
|
2011-03-31 |
2017-08-29 |
Abbott Diabetes Care Inc. |
Systems and methods for transcutaneously implanting medical devices
|
US9788771B2
(en)
|
2006-10-23 |
2017-10-17 |
Abbott Diabetes Care Inc. |
Variable speed sensor insertion devices and methods of use
|
US7883464B2
(en)
|
2005-09-30 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Integrated transmitter unit and sensor introducer mechanism and methods of use
|
US9636450B2
(en)
|
2007-02-19 |
2017-05-02 |
Udo Hoss |
Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
|
US9351669B2
(en)
|
2009-09-30 |
2016-05-31 |
Abbott Diabetes Care Inc. |
Interconnect for on-body analyte monitoring device
|
US7697967B2
(en)
|
2005-12-28 |
2010-04-13 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
US20090105569A1
(en)
|
2006-04-28 |
2009-04-23 |
Abbott Diabetes Care, Inc. |
Introducer Assembly and Methods of Use
|
US8571624B2
(en)
|
2004-12-29 |
2013-10-29 |
Abbott Diabetes Care Inc. |
Method and apparatus for mounting a data transmission device in a communication system
|
US9259175B2
(en)
|
2006-10-23 |
2016-02-16 |
Abbott Diabetes Care, Inc. |
Flexible patch for fluid delivery and monitoring body analytes
|
US8333714B2
(en)
|
2006-09-10 |
2012-12-18 |
Abbott Diabetes Care Inc. |
Method and system for providing an integrated analyte sensor insertion device and data processing unit
|
US8512243B2
(en)
|
2005-09-30 |
2013-08-20 |
Abbott Diabetes Care Inc. |
Integrated introducer and transmitter assembly and methods of use
|
US10226207B2
(en)
|
2004-12-29 |
2019-03-12 |
Abbott Diabetes Care Inc. |
Sensor inserter having introducer
|
US9572534B2
(en)
|
2010-06-29 |
2017-02-21 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US9398882B2
(en)
|
2005-09-30 |
2016-07-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor and data processing device
|
US8029441B2
(en)
|
2006-02-28 |
2011-10-04 |
Abbott Diabetes Care Inc. |
Analyte sensor transmitter unit configuration for a data monitoring and management system
|
IL166114A0
(en)
*
|
2005-01-03 |
2006-01-15 |
Calcident Active Ltd |
Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
|
ATE413864T1
(de)
*
|
2005-01-27 |
2008-11-15 |
Alza Corp |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
EP1685841A1
(en)
*
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
US20060185678A1
(en)
*
|
2005-02-03 |
2006-08-24 |
Bronnenkant Lance J |
Devices for delivering agents to a vaginal tract
|
EP1853272A1
(en)
*
|
2005-02-03 |
2007-11-14 |
Duramed Pharmaceuticals, Inc. |
Compositions of unconjugated estrogens and methods for their use
|
EP1690540A1
(en)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Composition comprising ocaperidone
|
US20060185665A1
(en)
*
|
2005-02-22 |
2006-08-24 |
Bachinski Thomas J |
Sauna fireplace
|
US20060194724A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Whitehurst Todd K |
Methods and systems for nerve regeneration
|
US20060204548A1
(en)
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
US7702385B2
(en)
*
|
2005-11-16 |
2010-04-20 |
Boston Scientific Neuromodulation Corporation |
Electrode contact configurations for an implantable stimulator
|
US7853321B2
(en)
*
|
2005-03-14 |
2010-12-14 |
Boston Scientific Neuromodulation Corporation |
Stimulation of a stimulation site within the neck or head
|
US8423155B1
(en)
|
2005-03-14 |
2013-04-16 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US7848803B1
(en)
|
2005-03-14 |
2010-12-07 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
EP1874269A2
(en)
*
|
2005-04-19 |
2008-01-09 |
Alza Corporation |
Combination of tramadol and substances that comprise gabapentin
|
US8112240B2
(en)
|
2005-04-29 |
2012-02-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing leak detection in data monitoring and management systems
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
US20070003624A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Shanbhag Anant R |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
DE102005031577A1
(de)
*
|
2005-07-06 |
2007-01-11 |
Bayer Healthcare Ag |
Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
|
US9447781B2
(en)
*
|
2005-07-22 |
2016-09-20 |
University Of Utah Research Foundation |
Osmotically driven dispense pump and related components for use in high pressure applications
|
NZ565953A
(en)
|
2005-07-27 |
2012-01-12 |
Univ Florida |
Small compounds that correct protein misfolding and uses thereof
|
US20070031496A1
(en)
*
|
2005-08-04 |
2007-02-08 |
Edgren David E |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070048347A1
(en)
*
|
2005-08-26 |
2007-03-01 |
Laura Bardach |
Intra-oral device for treating obesity
|
JP2009507224A
(ja)
|
2005-08-31 |
2009-02-19 |
ユニヴァーシティー オブ ヴァージニア パテント ファンデーション |
連続グルコースセンサの精度の改善
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US7684858B2
(en)
*
|
2005-09-21 |
2010-03-23 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for placing an implanted stimulator for stimulating tissue
|
DE102005045518A1
(de)
*
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
EP1933852B1
(en)
|
2005-09-27 |
2018-12-19 |
TissueTech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
US8187639B2
(en)
*
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
US8880138B2
(en)
|
2005-09-30 |
2014-11-04 |
Abbott Diabetes Care Inc. |
Device for channeling fluid and methods of use
|
US9521968B2
(en)
|
2005-09-30 |
2016-12-20 |
Abbott Diabetes Care Inc. |
Analyte sensor retention mechanism and methods of use
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
DE502006009169D1
(en)
|
2005-10-04 |
2011-05-05 |
Bayer Schering Pharma Ag |
NEUE POLYMORPHE FORM VON 5-CHLOR-N-(ä ( 5S )-2-0X0-3-Ä4-( 3-OXO-4-MORPHOLINYL)-PHENYLÜ-1,3-OXAZOLIDIN-5-YLü -METHYL)-2-THIOPHENCARBOXAMID
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US7766829B2
(en)
|
2005-11-04 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and system for providing basal profile modification in analyte monitoring and management systems
|
EP1948246B1
(en)
*
|
2005-11-14 |
2017-05-03 |
Theragene Pharmaceuticals, Inc. |
Stem cell factor therapy for tissue injury
|
MX2008006888A
(es)
|
2005-11-28 |
2008-09-30 |
Marinus Pharmaceuticals |
Formulas y metodos para la manufactura y uso de la ganaxolona.
|
AU2006320535B2
(en)
|
2005-11-29 |
2010-09-23 |
Glaxosmithkline Llc |
Treatment method
|
US7729758B2
(en)
*
|
2005-11-30 |
2010-06-01 |
Boston Scientific Neuromodulation Corporation |
Magnetically coupled microstimulators
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US11298058B2
(en)
|
2005-12-28 |
2022-04-12 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
EP1968432A4
(en)
|
2005-12-28 |
2009-10-21 |
Abbott Diabetes Care Inc |
INTRODUCTION OF A MEDICAL DEVICE
|
US7610100B2
(en)
*
|
2005-12-30 |
2009-10-27 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating osteoarthritis
|
US7835803B1
(en)
*
|
2006-01-17 |
2010-11-16 |
Boston Scientific Neuromodulation Corporation |
Lead assemblies with one or more switching networks
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US7736310B2
(en)
|
2006-01-30 |
2010-06-15 |
Abbott Diabetes Care Inc. |
On-body medical device securement
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
US7826879B2
(en)
|
2006-02-28 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Analyte sensors and methods of use
|
US7885698B2
(en)
|
2006-02-28 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Method and system for providing continuous calibration of implantable analyte sensors
|
US8309104B2
(en)
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
US8175710B2
(en)
*
|
2006-03-14 |
2012-05-08 |
Boston Scientific Neuromodulation Corporation |
Stimulator system with electrode array and the method of making the same
|
US7777641B2
(en)
*
|
2006-03-29 |
2010-08-17 |
Advanced Bionics, Llc |
Systems and methods of facilitating communication between a first and second device
|
US7801582B2
(en)
|
2006-03-31 |
2010-09-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management system and methods therefor
|
US8140312B2
(en)
|
2007-05-14 |
2012-03-20 |
Abbott Diabetes Care Inc. |
Method and system for determining analyte levels
|
US8374668B1
(en)
|
2007-10-23 |
2013-02-12 |
Abbott Diabetes Care Inc. |
Analyte sensor with lag compensation
|
US9675290B2
(en)
|
2012-10-30 |
2017-06-13 |
Abbott Diabetes Care Inc. |
Sensitivity calibration of in vivo sensors used to measure analyte concentration
|
US8224415B2
(en)
|
2009-01-29 |
2012-07-17 |
Abbott Diabetes Care Inc. |
Method and device for providing offset model based calibration for analyte sensor
|
US8219173B2
(en)
|
2008-09-30 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Optimizing analyte sensor calibration
|
US9339217B2
(en)
|
2011-11-25 |
2016-05-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods of use
|
US7618369B2
(en)
|
2006-10-02 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for dynamically updating calibration parameters for an analyte sensor
|
US7630748B2
(en)
|
2006-10-25 |
2009-12-08 |
Abbott Diabetes Care Inc. |
Method and system for providing analyte monitoring
|
US9392969B2
(en)
|
2008-08-31 |
2016-07-19 |
Abbott Diabetes Care Inc. |
Closed loop control and signal attenuation detection
|
US8346335B2
(en)
|
2008-03-28 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
US8583205B2
(en)
|
2008-03-28 |
2013-11-12 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
US8226891B2
(en)
|
2006-03-31 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods therefor
|
US7620438B2
(en)
|
2006-03-31 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for powering an electronic device
|
US8473022B2
(en)
|
2008-01-31 |
2013-06-25 |
Abbott Diabetes Care Inc. |
Analyte sensor with time lag compensation
|
US7653425B2
(en)
|
2006-08-09 |
2010-01-26 |
Abbott Diabetes Care Inc. |
Method and system for providing calibration of an analyte sensor in an analyte monitoring system
|
WO2007112581A1
(en)
*
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Controlled release delivery device comprising an organosol coat
|
WO2007121188A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
US10960077B2
(en)
*
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
ATE537826T1
(de)
*
|
2006-05-16 |
2012-01-15 |
Knopp Neurosciences Inc |
Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
|
US7920907B2
(en)
|
2006-06-07 |
2011-04-05 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and method
|
EP2526932B1
(en)
|
2006-06-19 |
2017-06-07 |
Alpharma Pharmaceuticals LLC |
Pharmaceutical composition
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8401654B1
(en)
|
2006-06-30 |
2013-03-19 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating one or more effects of deafferentation
|
US8504163B1
(en)
|
2006-06-30 |
2013-08-06 |
Boston Scientific Neuromodulation Corporation |
Cranially mounted stimulation systems and methods
|
CA2657435A1
(en)
|
2006-07-10 |
2008-07-03 |
Medipacs, Inc. |
Super elastic epoxy hydrogel
|
WO2008021368A2
(en)
|
2006-08-11 |
2008-02-21 |
The Johns Hopkins University |
Compositions and methods for neuroprotection
|
WO2008063727A2
(en)
*
|
2006-08-21 |
2008-05-29 |
United Therapeutics Corporation |
Combination therapy for treatment of viral infections
|
CN102887900B
(zh)
|
2006-09-22 |
2015-04-29 |
药品循环公司 |
布鲁顿酪氨酸激酶的抑制剂
|
US7445528B1
(en)
|
2006-09-29 |
2008-11-04 |
Boston Scientific Neuromodulation Corporation |
Connector assemblies
|
BRPI0718119A2
(pt)
|
2006-10-26 |
2014-07-08 |
Abbott Diabetes Care Inc |
Métodos, sistemas e programas de computador para a detecção em tempo real do declínio de sensibilidade em sensores de analito
|
US7347746B1
(en)
|
2006-10-27 |
2008-03-25 |
Boston Scientific Neuromodulation Corporation |
Receptacle connector assembly
|
DE102006051625A1
(de)
*
|
2006-11-02 |
2008-05-08 |
Bayer Materialscience Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
CA2670990A1
(en)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Method for determining optimum intraocular locations for drug delivery systems
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
EP2119442A4
(en)
|
2006-12-28 |
2010-12-15 |
Astellas Pharma Inc |
PHARMACEUTICAL COMPOSITION WITH TACROLIMUS MAINTAINED RELEASE
|
WO2008089260A2
(en)
*
|
2007-01-16 |
2008-07-24 |
Victory Pharma, Inc. |
Combined administration of benzonatate and guaifenesin
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US8121857B2
(en)
|
2007-02-15 |
2012-02-21 |
Abbott Diabetes Care Inc. |
Device and method for automatic data acquisition and/or detection
|
US20080199894A1
(en)
|
2007-02-15 |
2008-08-21 |
Abbott Diabetes Care, Inc. |
Device and method for automatic data acquisition and/or detection
|
US8732188B2
(en)
|
2007-02-18 |
2014-05-20 |
Abbott Diabetes Care Inc. |
Method and system for providing contextual based medication dosage determination
|
US8930203B2
(en)
|
2007-02-18 |
2015-01-06 |
Abbott Diabetes Care Inc. |
Multi-function analyte test device and methods therefor
|
US8123686B2
(en)
|
2007-03-01 |
2012-02-28 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing rolling data in communication systems
|
US8519148B2
(en)
*
|
2007-03-14 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
CA2683930A1
(en)
|
2007-04-14 |
2008-10-23 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
EP2146625B1
(en)
|
2007-04-14 |
2019-08-14 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
EP3741291A1
(en)
|
2007-04-14 |
2020-11-25 |
Abbott Diabetes Care, Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
EP2146623B1
(en)
|
2007-04-14 |
2014-01-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
US9615780B2
(en)
|
2007-04-14 |
2017-04-11 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
WO2008130895A2
(en)
|
2007-04-14 |
2008-10-30 |
Abbott Diabetes Care, Inc. |
Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
US8456301B2
(en)
|
2007-05-08 |
2013-06-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US7928850B2
(en)
|
2007-05-08 |
2011-04-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8665091B2
(en)
|
2007-05-08 |
2014-03-04 |
Abbott Diabetes Care Inc. |
Method and device for determining elapsed sensor life
|
US8461985B2
(en)
|
2007-05-08 |
2013-06-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8239166B2
(en)
|
2007-05-14 |
2012-08-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US7996158B2
(en)
|
2007-05-14 |
2011-08-09 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8560038B2
(en)
|
2007-05-14 |
2013-10-15 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8600681B2
(en)
|
2007-05-14 |
2013-12-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US10002233B2
(en)
|
2007-05-14 |
2018-06-19 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8260558B2
(en)
|
2007-05-14 |
2012-09-04 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US9125548B2
(en)
|
2007-05-14 |
2015-09-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8103471B2
(en)
|
2007-05-14 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8444560B2
(en)
|
2007-05-14 |
2013-05-21 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US20200037874A1
(en)
|
2007-05-18 |
2020-02-06 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US20080306434A1
(en)
|
2007-06-08 |
2008-12-11 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
CA2690742C
(en)
|
2007-06-21 |
2018-05-15 |
Abbott Diabetes Care Inc. |
Health management devices and methods
|
EP3473167A1
(en)
|
2007-06-21 |
2019-04-24 |
Abbott Diabetes Care, Inc. |
Health monitor
|
US8160900B2
(en)
|
2007-06-29 |
2012-04-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
|
US7768386B2
(en)
|
2007-07-31 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8834366B2
(en)
|
2007-07-31 |
2014-09-16 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor calibration
|
WO2009032286A2
(en)
*
|
2007-09-06 |
2009-03-12 |
Nektar Therapeutics Al, Corporation |
Oligomer-calcium channel blocker conjugates
|
CA2699157A1
(en)
|
2007-09-10 |
2009-03-19 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US20090088681A1
(en)
*
|
2007-10-02 |
2009-04-02 |
Mcintyre Jon T |
Device and method for the treatment of intra-abdominal disease
|
EP4159114B1
(en)
|
2007-10-09 |
2024-04-10 |
DexCom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
US8409093B2
(en)
|
2007-10-23 |
2013-04-02 |
Abbott Diabetes Care Inc. |
Assessing measures of glycemic variability
|
US8216138B1
(en)
|
2007-10-23 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
|
US8377031B2
(en)
*
|
2007-10-23 |
2013-02-19 |
Abbott Diabetes Care Inc. |
Closed loop control system with safety parameters and methods
|
JP2011505520A
(ja)
*
|
2007-12-03 |
2011-02-24 |
メディパックス インコーポレイテッド |
流体計量供給装置
|
WO2009088414A2
(en)
|
2007-12-06 |
2009-07-16 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20090164239A1
(en)
|
2007-12-19 |
2009-06-25 |
Abbott Diabetes Care, Inc. |
Dynamic Display Of Glucose Information
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
EP2242485A4
(en)
*
|
2008-02-15 |
2013-05-08 |
Sun Pharma Advanced Res Co Ltd |
ORAL TABLET WITH CONTROLLED RELEASE
|
EP2982383B1
(en)
|
2008-04-10 |
2019-05-15 |
Abbott Diabetes Care, Inc. |
Method for sterilizing an analyte sensor
|
US7826382B2
(en)
|
2008-05-30 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Close proximity communication device and methods
|
US8591410B2
(en)
|
2008-05-30 |
2013-11-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US8924159B2
(en)
|
2008-05-30 |
2014-12-30 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
WO2010009172A1
(en)
|
2008-07-14 |
2010-01-21 |
Abbott Diabetes Care Inc. |
Closed loop control system interface and methods
|
US20110190356A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Knopp Neurosciences Inc. |
Compositions and Methods of Using (R)- Pramipexole
|
AU2009288245B2
(en)
|
2008-08-27 |
2012-12-20 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US9943644B2
(en)
|
2008-08-31 |
2018-04-17 |
Abbott Diabetes Care Inc. |
Closed loop control with reference measurement and methods thereof
|
US8734422B2
(en)
|
2008-08-31 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Closed loop control with improved alarm functions
|
US8622988B2
(en)
|
2008-08-31 |
2014-01-07 |
Abbott Diabetes Care Inc. |
Variable rate closed loop control and methods
|
US20100057040A1
(en)
|
2008-08-31 |
2010-03-04 |
Abbott Diabetes Care, Inc. |
Robust Closed Loop Control And Methods
|
US8986208B2
(en)
|
2008-09-30 |
2015-03-24 |
Abbott Diabetes Care Inc. |
Analyte sensor sensitivity attenuation mitigation
|
WO2010039801A2
(en)
|
2008-10-02 |
2010-04-08 |
The J. David Gladstone Institutes |
Methods of treating hepatitis c virus infection
|
US20100104654A1
(en)
*
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US9326707B2
(en)
|
2008-11-10 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Alarm characterization for analyte monitoring devices and systems
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
DE102008059206A1
(de)
|
2008-11-27 |
2010-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
|
SG173167A1
(en)
|
2009-01-29 |
2011-08-29 |
Forsight Labs Llc |
Posterior segment drug delivery
|
US8103456B2
(en)
|
2009-01-29 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and device for early signal attenuation detection using blood glucose measurements
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US20100198034A1
(en)
|
2009-02-03 |
2010-08-05 |
Abbott Diabetes Care Inc. |
Compact On-Body Physiological Monitoring Devices and Methods Thereof
|
US20100204325A1
(en)
*
|
2009-02-11 |
2010-08-12 |
Allergan, Inc. |
Valproic acid drug delivery systems and intraocular therapeutic uses thereof
|
EP2408449A4
(en)
|
2009-03-18 |
2012-08-08 |
Univ Leland Stanford Junior |
METHODS AND COMPOSITIONS FOR TREATING INFECTION WITH A FLAVIVIRIDAE FAMILY VIRUS
|
WO2010121084A1
(en)
|
2009-04-15 |
2010-10-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring system having an alert
|
CA2758571A1
(en)
|
2009-04-24 |
2010-10-28 |
Tissuetech, Inc. |
Compositions containing hc-ha complex and methods of use thereof
|
WO2010127050A1
(en)
|
2009-04-28 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Error detection in critical repeating data in a wireless sensor system
|
EP2424426B1
(en)
|
2009-04-29 |
2020-01-08 |
Abbott Diabetes Care, Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
WO2010127051A1
(en)
|
2009-04-29 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Method and system for providing real time analyte sensor calibration with retrospective backfill
|
US20100278897A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Intraocular bioactive agent delivery system with molecular partitioning system
|
US8372036B2
(en)
*
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
WO2010138856A1
(en)
|
2009-05-29 |
2010-12-02 |
Abbott Diabetes Care Inc. |
Medical device antenna systems having external antenna configurations
|
BRPI0925100A2
(pt)
|
2009-06-02 |
2016-07-19 |
Dow Global Technologies Llc |
forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
|
IN2012DN00352A
(es)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
JP2012530723A
(ja)
*
|
2009-06-19 |
2012-12-06 |
ノップ ニューロサイエンシーズ、インク. |
筋萎縮性側索硬化症を治療するための組成物及び方法
|
US8613892B2
(en)
|
2009-06-30 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Analyte meter with a moveable head and methods of using the same
|
EP3689237B1
(en)
|
2009-07-23 |
2021-05-19 |
Abbott Diabetes Care, Inc. |
Method of manufacturing and system for continuous analyte measurement
|
WO2011014851A1
(en)
|
2009-07-31 |
2011-02-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte monitoring system calibration accuracy
|
CN102573813B
(zh)
*
|
2009-08-18 |
2013-11-06 |
国立大学法人东北大学 |
持续药物传递系统
|
DK4070729T3
(da)
|
2009-08-31 |
2024-05-21 |
Abbott Diabetes Care Inc |
Visningsindretninger til en medicinsk indretning
|
US8993331B2
(en)
|
2009-08-31 |
2015-03-31 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods for managing power and noise
|
WO2011026147A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Analyte signal processing device and methods
|
EP2473963A4
(en)
|
2009-08-31 |
2014-01-08 |
Abbott Diabetes Care Inc |
MEDICAL DEVICES AND METHOD
|
US9238102B2
(en)
|
2009-09-10 |
2016-01-19 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
DE102009042855A1
(de)
*
|
2009-09-24 |
2011-03-31 |
Pfenning Elektroanlagen Gmbh |
Portalhubwagen zum Einsatz in Containerterminals und für allgemeine Transportaufgaben
|
WO2011041469A1
(en)
|
2009-09-29 |
2011-04-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing notification function in analyte monitoring systems
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
US8185181B2
(en)
|
2009-10-30 |
2012-05-22 |
Abbott Diabetes Care Inc. |
Method and apparatus for detecting false hypoglycemic conditions
|
MX361709B
(es)
|
2009-11-09 |
2018-12-07 |
Allergan Inc |
Composiciones y metodos para estimular el crecimiento del cabello.
|
US20120245505A1
(en)
|
2009-12-16 |
2012-09-27 |
Robinson Michael R |
Intracameral devices for sustained delivery
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
CA2785468A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
US20110172637A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Drug delivery device including tissue support structure
|
US20110172645A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Wearable drug delivery device including integrated pumping and activation elements
|
US20110172639A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Device and method for delivery of microneedle to desired depth within the skin
|
US20110172609A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
USD924406S1
(en)
|
2010-02-01 |
2021-07-06 |
Abbott Diabetes Care Inc. |
Analyte sensor inserter
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
WO2011112753A1
(en)
|
2010-03-10 |
2011-09-15 |
Abbott Diabetes Care Inc. |
Systems, devices and methods for managing glucose levels
|
BRPI1105778A2
(pt)
|
2010-03-24 |
2016-05-03 |
Abbott Diabetes Care Inc |
"insersores de dispositivo médico e processos de inserção e uso de dispositivos médicos"
|
PT2554168T
(pt)
|
2010-03-29 |
2018-02-28 |
Astellas Pharma Inc |
Composição farmacêutica de libertação controlada
|
ES2602475T3
(es)
|
2010-04-15 |
2017-02-21 |
Tracon Pharmaceuticals, Inc. |
Potenciación de la actividad anticáncer por terapia de combinación con inhibidores de la vía BER
|
EP2563759B1
(en)
|
2010-04-27 |
2022-04-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
AU2011248877B9
(en)
|
2010-04-27 |
2015-11-05 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
EA031737B1
(ru)
|
2010-06-03 |
2019-02-28 |
Фармасайкликс, Инк. |
Применение ингибиторов тирозинкиназы брутона (btk) для лечения лейкоза и лимфомы
|
US8635046B2
(en)
|
2010-06-23 |
2014-01-21 |
Abbott Diabetes Care Inc. |
Method and system for evaluating analyte sensor response characteristics
|
US11064921B2
(en)
|
2010-06-29 |
2021-07-20 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US10092229B2
(en)
|
2010-06-29 |
2018-10-09 |
Abbott Diabetes Care Inc. |
Calibration of analyte measurement system
|
EP2600930B1
(en)
|
2010-08-05 |
2021-02-17 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
JP5907966B2
(ja)
|
2010-08-05 |
2016-04-26 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
埋め込み型治療デバイス
|
US9079891B2
(en)
|
2010-08-27 |
2015-07-14 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US11213226B2
(en)
|
2010-10-07 |
2022-01-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods
|
WO2012061556A1
(en)
|
2010-11-03 |
2012-05-10 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US8518440B2
(en)
|
2010-12-21 |
2013-08-27 |
Confluent Surgical, Inc. |
Biodegradable osmotic pump implant for drug delivery
|
PT2665477E
(pt)
|
2011-01-20 |
2016-01-12 |
Bionevia Pharmaceuticals Inc |
Composições de libertação modificada de epalrestat ou de um seu derivado e métodos para a sua utilização
|
US8801768B2
(en)
*
|
2011-01-21 |
2014-08-12 |
Endologix, Inc. |
Graft systems having semi-permeable filling structures and methods for their use
|
US10136845B2
(en)
|
2011-02-28 |
2018-11-27 |
Abbott Diabetes Care Inc. |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
CN107019515B
(zh)
|
2011-02-28 |
2021-02-26 |
雅培糖尿病护理公司 |
显示传感器读数的方法与分析物监测装置及其操作方法
|
DE102011007272A1
(de)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
|
US9848809B2
(en)
|
2011-04-15 |
2017-12-26 |
Dexcom, Inc. |
Advanced analyte sensor calibration and error detection
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
JP6068457B2
(ja)
|
2011-06-14 |
2017-01-25 |
ビカム ファーマスーティカルス,インコーポレイテッド |
化合物及び組成物
|
WO2012175698A1
(en)
|
2011-06-23 |
2012-12-27 |
Université Libre de Bruxelles |
Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
WO2013006643A1
(en)
*
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
JP2014527801A
(ja)
|
2011-09-01 |
2014-10-23 |
ユニバーシティ オブ サザン カリフォルニア |
ハイスループットペプチドミメティックを調製するための方法、経口バイオアベイラブルな薬物およびそれを含有する組成物
|
UA110853C2
(uk)
|
2011-09-13 |
2016-02-25 |
Фармасайклікс, Інк. |
Лікарські форми інгібітора гістондеацетилази у комбінації з бендамустином та їхнє застосування
|
CA2848385C
(en)
|
2011-09-16 |
2021-10-26 |
Forsight Vision4, Inc. |
Methods and apparatus to exchange a fluid of an implantable device
|
US9499464B2
(en)
|
2011-10-19 |
2016-11-22 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
US9069536B2
(en)
|
2011-10-31 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Electronic devices having integrated reset systems and methods thereof
|
US9622691B2
(en)
|
2011-10-31 |
2017-04-18 |
Abbott Diabetes Care Inc. |
Model based variable risk false glucose threshold alarm prevention mechanism
|
US9980669B2
(en)
|
2011-11-07 |
2018-05-29 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US8710993B2
(en)
|
2011-11-23 |
2014-04-29 |
Abbott Diabetes Care Inc. |
Mitigating single point failure of devices in an analyte monitoring system and methods thereof
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
US9317656B2
(en)
|
2011-11-23 |
2016-04-19 |
Abbott Diabetes Care Inc. |
Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
EP2785178B1
(en)
|
2011-12-01 |
2019-05-01 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
CN104066432B
(zh)
|
2011-12-06 |
2017-06-13 |
小利兰·斯坦福大学董事会 |
用于治疗病毒性疾病的方法和组合物
|
US9402570B2
(en)
|
2011-12-11 |
2016-08-02 |
Abbott Diabetes Care Inc. |
Analyte sensor devices, connections, and methods
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
LT2800565T
(lt)
|
2012-01-06 |
2020-07-27 |
Lundbeck La Jolla Research Center, Inc. |
Karbamato junginiai ir jų gamybos būdai ir panaudojimai
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
WO2013123432A2
(en)
|
2012-02-16 |
2013-08-22 |
Atyr Pharma, Inc. |
Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
|
CN104302689A
(zh)
|
2012-03-14 |
2015-01-21 |
麦德医像公司 |
含有过量活性分子的智能聚合物材料
|
MX2014013320A
(es)
|
2012-05-07 |
2015-08-10 |
Bayer Pharma AG |
Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo.
|
CA2875986C
(en)
|
2012-06-04 |
2020-06-09 |
Pharmacyclics, Inc. |
Crystalline forms of a bruton's tyrosine kinase inhibitor
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
UY34856A
(es)
|
2012-07-03 |
2013-12-31 |
Bayer Pharma AG |
Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
|
EP3838293A1
(en)
|
2012-07-11 |
2021-06-23 |
Tissuetech, Inc. |
Compositions containing hc-ha/ptx3 complexes and methods of use thereof
|
WO2014035732A1
(en)
|
2012-08-30 |
2014-03-06 |
Abbot Diabetes Care Inc. |
Dropout detection in continuous analyte monitoring data during data excursions
|
US9968306B2
(en)
|
2012-09-17 |
2018-05-15 |
Abbott Diabetes Care Inc. |
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
|
EP2901153A4
(en)
|
2012-09-26 |
2016-04-27 |
Abbott Diabetes Care Inc |
METHOD AND DEVICE FOR IMPROVING DELAY CORRECTION FUNCTION DURING IN VIVO MEASUREMENT OF ANALYZ CONCENTRATION WITH ANALYZ CONCENTRATION VARIABILITY AND RANGE DATA
|
WO2014052914A1
(en)
|
2012-09-28 |
2014-04-03 |
University Of Washington Through Its Center For Commercialization |
Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
|
EP3692981B1
(en)
|
2012-10-11 |
2022-05-04 |
Chem-Cure Associates LLC |
Topical composition for use in the treatment of psoriasis
|
US9717741B2
(en)
|
2012-10-11 |
2017-08-01 |
Anaplasi Pharmaceuticals Llc |
Method and compositions for treating psoriasis
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
GB2510826B
(en)
|
2013-02-13 |
2015-09-02 |
Animax Ltd |
Improvements in or relating to release of a beneficial substance from a bolus
|
JP6511401B2
(ja)
|
2013-02-15 |
2019-05-15 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
持続型薬物送達インプラント
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
WO2014152034A1
(en)
|
2013-03-15 |
2014-09-25 |
Abbott Diabetes Care Inc. |
Sensor fault detection using analyte sensor data pattern comparison
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US10433773B1
(en)
|
2013-03-15 |
2019-10-08 |
Abbott Diabetes Care Inc. |
Noise rejection methods and apparatus for sparsely sampled analyte sensor data
|
US9474475B1
(en)
|
2013-03-15 |
2016-10-25 |
Abbott Diabetes Care Inc. |
Multi-rate analyte sensor data collection with sample rate configurable signal processing
|
EP4302736A3
(en)
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
PT3019167T
(pt)
|
2013-07-12 |
2021-03-04 |
Knopp Biosciences Llc |
Tratamento de níveis elevados de eosinófilos e/ou basófilos
|
US9642840B2
(en)
|
2013-08-13 |
2017-05-09 |
Knopp Biosciences, Llc |
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
|
AU2014306597B2
(en)
|
2013-08-13 |
2018-05-17 |
Knopp Biosciences Llc |
Compositions and methods for treating chronic urticaria
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
AU2014360446A1
(en)
|
2013-12-05 |
2016-06-09 |
Pharmacyclics, Llc |
Inhibitors of Bruton's tyrosine kinase
|
AU2014374361B9
(en)
|
2013-12-31 |
2019-07-04 |
Abbott Diabetes Care Inc. |
Self-powered analyte sensor and devices using the same
|
WO2015153482A1
(en)
|
2014-03-30 |
2015-10-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for determining meal start and peak events in analyte monitoring systems
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
KR102416726B1
(ko)
|
2014-07-15 |
2022-07-05 |
포사이트 비젼4, 인크. |
안구 이식물 전달 디바이스 및 방법
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
WO2016016770A1
(en)
|
2014-07-26 |
2016-02-04 |
Wockhardt Limited |
A novel modified release pharmaceutical composition of sitagliptin or pharmaceutically acceptable salt thereof
|
JP2017524034A
(ja)
|
2014-08-08 |
2017-08-24 |
フォーサイト・ビジョン フォー・インコーポレーテッドForsight Vision4, Inc. |
受容体型チロシンキナーゼ阻害剤の安定で可溶な製剤およびその調製の方法
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
AU2015346450B2
(en)
|
2014-11-10 |
2020-01-30 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
CA2974324A1
(en)
|
2015-01-28 |
2016-08-04 |
Zita S. Netzel |
Drug delivery methods and systems
|
US9493482B2
(en)
|
2015-02-06 |
2016-11-15 |
University Of Washington |
Compounds and methods for preventing or treating sensory hair cell death
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
WO2016132218A1
(en)
|
2015-02-20 |
2016-08-25 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Method of administering r-baclofen in an extended release dosage form
|
TW201642914A
(zh)
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
用於治療眼部疾病及失調的裝置及方法
|
MX2017011018A
(es)
|
2015-02-27 |
2018-01-18 |
Curtana Pharmaceuticals Inc |
Inhibicion de la actividad de olig2.
|
MD3265084T2
(ro)
|
2015-03-03 |
2024-05-31 |
Pharmacyclics Llc |
Formulări farmaceutice ale inhibitorului tirozin kinazei Bruton
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
MA41828A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
|
MA41827A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton
|
US10575976B2
(en)
|
2015-04-30 |
2020-03-03 |
Dynamic Mouth Devices, L.L.C. |
Method and apparatus for weight management utilizing an intra-oral device
|
EP3294731A4
(en)
|
2015-05-11 |
2018-10-24 |
Abide Therapeutics, Inc. |
Methods of treating inflammation or neuropathic pain
|
US10213139B2
(en)
|
2015-05-14 |
2019-02-26 |
Abbott Diabetes Care Inc. |
Systems, devices, and methods for assembling an applicator and sensor control device
|
CA2984939A1
(en)
|
2015-05-14 |
2016-11-17 |
Abbott Diabetes Care Inc. |
Compact medical device inserters and related systems and methods
|
TWI720984B
(zh)
|
2015-05-20 |
2021-03-11 |
美商帝聖工業公司 |
用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
|
WO2017011346A1
(en)
|
2015-07-10 |
2017-01-19 |
Abbott Diabetes Care Inc. |
System, device and method of dynamic glucose profile response to physiological parameters
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
CA2993009A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
JP2018525411A
(ja)
|
2015-08-31 |
2018-09-06 |
ファーマサイクリックス エルエルシー |
多発性骨髄腫を治療するためのbtk阻害剤の組み合わせ
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
CA3005238A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
ES2952064T3
(es)
|
2015-12-16 |
2023-10-26 |
Walter & Eliza Hall Inst Medical Res |
Inhibición de la proteína SH2 inducida por citocinas en células NK
|
JP7336195B2
(ja)
|
2016-01-19 |
2023-08-31 |
ヤンセン ファーマシューティカ エヌ.ベー. |
Btk阻害剤を含む製剤/組成物
|
MA43649A
(fr)
|
2016-01-19 |
2018-11-28 |
Janssen Pharmaceutica Nv |
Formulations/compositions comprenant un inhibiteur de btk
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
CA3020153A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
EP3442538A4
(en)
|
2016-04-04 |
2019-11-20 |
Sinopia Biosciences, Inc. |
TREATMENT OF EXTRAPYRAMIDAL SYNDROME WITH TRAPIDILE
|
BR112018070383A2
(pt)
|
2016-04-05 |
2019-02-05 |
Forsight Vision4 Inc |
dispositivos para aplicação de fármaco oculares implantáveis
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US10821105B2
(en)
|
2016-05-25 |
2020-11-03 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
JP2019524747A
(ja)
|
2016-07-18 |
2019-09-05 |
アースローシ セラピューティクス,インク. |
痛風または高尿酸血症に関連する症状を処置または予防するための化合物、組成物、および方法
|
KR102605329B1
(ko)
|
2016-08-26 |
2023-11-22 |
커타나 파마슈티칼스, 인크. |
Olig2 활성의 억제
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
JP7042548B2
(ja)
|
2016-11-16 |
2022-03-28 |
ルンドベック ラ ホーヤ リサーチ センター,インク. |
Magl阻害剤の結晶形態
|
TN2019000148A1
(en)
|
2016-11-16 |
2020-10-05 |
Abide Therapeutics Inc |
Pharmaceutical formulations
|
AU2018206560A1
(en)
|
2017-01-04 |
2019-07-18 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
JP7514621B2
(ja)
|
2017-01-04 |
2024-07-11 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Dnabiiワクチンおよび強化された活性を有する抗体
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
EP3570735A4
(en)
|
2017-01-23 |
2020-10-21 |
Abbott Diabetes Care Inc. |
SYSTEMS, DEVICES AND METHODS FOR INSERTING ANALYTE SENSOR
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
WO2018175489A1
(en)
|
2017-03-21 |
2018-09-27 |
Abbott Diabetes Care Inc. |
Methods, devices and system for providing diabetic condition diagnosis and therapy
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
US11779573B2
(en)
|
2017-09-01 |
2023-10-10 |
University Of Washington |
Crystalline forms of compounds for preventing or treating sensory hair cell death
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US20190117131A1
(en)
|
2017-10-24 |
2019-04-25 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US11331022B2
(en)
|
2017-10-24 |
2022-05-17 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
CA3082891A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
CA3091259A1
(en)
|
2018-02-16 |
2019-08-22 |
Esperion Therapeutics, Inc. |
Sustained release formulations of bempedoic acid
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
CN111526872B
(zh)
|
2018-02-28 |
2022-05-17 |
上海汉都医药科技有限公司 |
一种药物组合物及其制备方法和应用
|
US11000471B2
(en)
|
2018-03-05 |
2021-05-11 |
Kashiv Specialty Pharmaceuticals, Llc |
Programmable pharmaceutical compositions for chrono drug release
|
JP7125791B2
(ja)
|
2018-05-23 |
2022-08-25 |
シャンハイ ダブリュディー ファーマシューティカル カンパニー,リミティド |
活性薬物成分の放出制御システムおよびその製造方法
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
MA53368A
(fr)
|
2018-07-24 |
2021-06-02 |
Bayer Ag |
Formes galéniques pharmaceutiques à libération modifiée à administrer par voie orale
|
CA3107174A1
(en)
|
2018-07-24 |
2020-01-30 |
Bayer Aktiengesellschaft |
Pharmaceutical dosage form which can be administered orally and has modified release
|
US10905667B2
(en)
|
2018-07-24 |
2021-02-02 |
Bayer Pharma Aktiengesellschaft |
Orally administrable modified-release pharmaceutical dosage form
|
CA3107433A1
(en)
|
2018-07-27 |
2020-01-30 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic trpv1 agonists
|
EP3906026A4
(en)
|
2018-12-31 |
2022-10-19 |
Biomea Fusion, LLC |
IRREVERSIBLE MENIN-MLL INTERACTION INHIBITORS
|
MX2021011081A
(es)
|
2019-03-15 |
2022-01-18 |
Unicycive Therapeutics Inc |
Derivados de nicorandil.
|
USD1002852S1
(en)
|
2019-06-06 |
2023-10-24 |
Abbott Diabetes Care Inc. |
Analyte sensor device
|
EP3750528A1
(en)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Compositions for treating dystrophies and myotonia
|
EP4361171A2
(en)
|
2019-07-08 |
2024-05-01 |
Research Institute at Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
JP2023523219A
(ja)
|
2020-04-21 |
2023-06-02 |
ハー・ルンドベック・アクチエゼルスカベット |
モノアシルグリセロールリパーゼ阻害剤の合成
|
PT4153136T
(pt)
|
2020-06-10 |
2024-03-22 |
Auspex Pharmaceuticals Inc |
Formas de dosagem osmótica que compreendem deutetrabenazina e métodos de utilização da mesma
|
EP4263542A1
(en)
|
2020-12-16 |
2023-10-25 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
USD999913S1
(en)
|
2020-12-21 |
2023-09-26 |
Abbott Diabetes Care Inc |
Analyte sensor inserter
|
CA3204457A1
(en)
|
2021-01-06 |
2022-07-14 |
Ben SESSA |
Mdma in the treatment of alcohol use disorder
|
US20240190809A1
(en)
|
2021-05-11 |
2024-06-13 |
Awakn Ls Europe Holdings Limited |
Therapeutic aminoindane compounds and compositions
|
WO2022247952A1
(zh)
*
|
2021-05-28 |
2022-12-01 |
上海博志研新药物技术有限公司 |
硝苯地平美托洛尔缓释组合物、其制备方法及应用
|
AU2022283967A1
(en)
|
2021-06-03 |
2024-01-18 |
Arcadia Medicine, Inc. |
Enantiomeric entactogen compositions and methods of their use
|
TW202320796A
(zh)
|
2021-08-11 |
2023-06-01 |
美商拜歐米富士恩股份有限公司 |
用於糖尿病的menin-mll相互作用之共價抑制劑
|
AU2022331496A1
(en)
|
2021-08-20 |
2024-02-29 |
Biomea Fusion, Inc. |
Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
KR20230071712A
(ko)
|
2021-11-16 |
2023-05-23 |
오즈온바이오 주식회사 |
산 민감성 무기성분을 포함하는 삼투성 제제 조성물
|
EP4370506A1
(en)
|
2021-12-30 |
2024-05-22 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of flt3
|
WO2023139163A1
(en)
|
2022-01-19 |
2023-07-27 |
Awakn Ls Europe Holdings Limited |
1,3-benzodioxole esters and their therapeutic use
|
CN115490316B
(zh)
*
|
2022-01-24 |
2023-09-12 |
成都理工大学 |
一种可再利用的地下水营养物质缓释胶囊体
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
WO2023156565A1
(en)
|
2022-02-16 |
2023-08-24 |
Awakn Ls Europe Holdings Limited |
Bridged ring compounds and their therapeutic use as cns agents
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
WO2023240186A1
(en)
|
2022-06-08 |
2023-12-14 |
Auspex Pharmaceuticals, Inc. |
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
|
US20240010649A1
(en)
|
2022-07-06 |
2024-01-11 |
Oppilan Pharma Limited |
Crystalline forms of an s1p receptor modulator
|
US11931224B1
(en)
*
|
2022-12-19 |
2024-03-19 |
Robert Parker |
Tooth pod
|